CBR Systems Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CBR Systems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011785
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc is a stem cell company that offers newborn stem cells. The company designs and implements technologies and processes for cord blood banking. It offers cord blood banking service that stores newborn’s umbilical cord blood; and cord blood and cord tissue banking that gives access to a range of stem cells. CBR offers various types of cells that are evaluated in potential therapies for autoimmune and inflammatory disease, cancers, diabetes, gastrointestinal disease, heart and vascular disease and others. The company’s stem cells are used in the treatment of acute myelofibrosis, agnogenic myeloid metaplasia, blackfan-diamond anemia, and others. CBR Systems is headquartered in San Bruno, California, the US.

CBR Systems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CBR Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
CBR Systems Inc, Pharmaceuticals & Healthcare, Deal Details 9
Private Equity 9
GTCR Invests In Cord Blood Registry 9
Partnerships 10
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 10
Acquisition 11
AMAG Pharma Acquires Cord Blood Registry for USD700 Million 11
CBR Systems Inc – Key Competitors 13
CBR Systems Inc – Key Employees 14
CBR Systems Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
CBR Systems Inc, Pharmaceuticals & Healthcare, Key Facts 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CBR Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CBR Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
GTCR Invests In Cord Blood Registry 9
Cord Blood Registry Enters into Research Agreement with Cellular Dynamics 10
AMAG Pharma Acquires Cord Blood Registry for USD700 Million 11
CBR Systems Inc, Key Competitors 13
CBR Systems Inc, Key Employees 14

★海外企業調査レポート[CBR Systems Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Peninsula Minerals Limited (PEN):企業概要、財務及び戦略的SWOT分析
    Summary Peninsula Minerals Limited (PEN) is a mineral exploration company. The company acquires, develops and explores uranium assets in Wyoming, the US and Karoo, South Africa. Its projects include Lance project, Karoo and RAKI RAKI gold project. PEN’s Lance project is located on the North-East fla …
  • Pan-International Industrial Corporation (2328):企業概要、財務及び戦略的SWOT分析
    Summary Pan-International Industrial Corporation (Pan-International) is an electronic manufacturing service (EMS) provider. The company provides manufacturing services for a spectrum of capabilities including bulk wire, cable and connectors, cable assemblies, and PCBA and turnkey systems assembly, a …
  • Statkraft SCA Vind AB:企業のM&A・提携動向(発電分野)
    Summary Statkraft SCA Vind AB (Statkraft SCA), a subsidiary of Statkraft AS is a renewable energy company that owns and operates wind power projects for the generation of electricity. The company provides logging and road building, casting and reinforce the foundation, transport, and fit and lift. I …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • JTEKT Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JTEKT Corporation Mergers and A …
  • Mocon Inc (MOCO):企業財務及び戦略的SWOT分析
    Summary Mocon Inc (MOCON), formerly Modern Controls, Inc. is a construction equipment company that manufactures measuring instruments. The company’s products include package integrity test system, bundle promotion, platinum analyzer and platinum oxygen analyzer. It provides GreenLight 930, OX-TRAN m …
  • Kuwait Foreign Petroleum Exploration Company K.S.C.:企業のM&A・提携動向(石油・ガス分野)
    Summary Kuwait Foreign Petroleum Exploration Company K.S.C. (KUFPEC), a subsidiary of Kuwait Petroleum Corporation (KPC), explores, develops and produces crude oil and natural gas. KUFPEC key asset base consists of offshore and onshore exploration leases, oil and gas properties and appraisal and dev …
  • ViroMed Co Ltd (084990):企業財務及び戦略的SWOT分析
    Summary ViroMed Co Ltd (ViroMed), formerly ViroMedica Pacifica is a biotechnology company that develops and manufactures biopharmaceuticals and phytotherapeutics. The company develops therapeutic drugs such as therapeutic angiogenesis for cardiovascular diseases, therapeutic cancer vaccine and prote …
  • FTI Consulting, Inc.:企業のM&A・提携・投資分析
    FTI Consulting, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FTI Consulting, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Hemanext:医療機器:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Tulmar Safety Systems Inc.:企業概要及びSWOT分析
    Product Synopsis SDI's "Tulmar Safety Systems Inc.: Aerospace and Defense - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Sanlam Limited:企業の戦略・SWOT・財務分析
    SummarySanlam Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • ALS Ltd (ALQ):石油・ガス:M&Aディール及び事業提携情報
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides offers chemical and laboratory services, technical testing and inspection servic …
  • Reliance Insurance Limited:企業の戦略・SWOT・財務情報
    Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mubadala Petroleum LLC:企業のM&A・提携動向(石油・ガス分野)
    Summary Mubadala Petroleum LLC (Mubadala Petroleum), a subsidiary of Mubadala Development Company (Mubadala) is an upstream oil and gas company that carries out the exploration, development, and production of oil and gas. The company operates its oil and gas assets in all stages of the upstream valu …
  • GKN plcの企業概要及び財務/SWOT分析
    GKN plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts mad …
  • Hubbell Incorporated:企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AMB Property Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AMB Property Corporation Merger …
  • Axiogenesis AG(製薬・医療分野):企業M&A動向
    Summary Axiogenesis AG (Axiogenesis) is a biotechnology company. The company develops vitro models of healthy and diseased cell types and tissue. Its products include human ipsc cardiomyocytes, murine cardiomyocytes, endothelial cells and smooth muscle cells. Axiogenesis offers kits including Cor.At …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆